Spondylitis ankylopoetica (Bechterew-kór): ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• IL-17 3
• TNF 2
• JAK 1
• IL-23 1
• NLRP3 0
• STAT3 0
• TLR4 0
• COX-2 0
• IL-6 0
• MAPK 0
• NRF2 0
• PD-1 0
• AKT 0
• AXL 0
• BDNF 0
• CD40 0
• CGRP 0
• CXCR4 0
• ERK 0
• FAK 0
• G6PD 0
• HIF-1 0
• IL-1 0
• IL-15 0
• MEK 0
• NF1 0
• PD-L1 0
• PI3K 0
• PIK3CA 0
• PPAR 0
• PTEN 0
• RANKL 0
• VEGF 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIAMS · R56

  Identifying pre-osteoarthritis endotypes and mechanisms

  Hebrew Rehabilitation Center for Aged· Boston, Egyesült Államok· 604 389 USD awarded in fiscal year 2026· until 2027. aug.

• NIH NIAMS · R01

  Defining Early Events in the Pathogenesis of Axial Spondyloarthritis

  Washington University· Saint Louis, Egyesült Államok· 546 057 USD awarded in fiscal year 2026· until 2031. aug.

• NIH NIAID · R03

  Understanding the Development of Human Type 17 CD8 T Cells

  Washington University· Saint Louis, Egyesült Államok· 77 750 USD awarded in fiscal year 2026· until 2028. aug.

• NIH NIAMS · K08

  Use of Antenatal Disease Modifying Antirheumatic Drugs and Maternal-child Health Among Women with Chronic Inflammatory Arthritis

  Yale University· New Haven, Egyesült Államok· 160 024 USD awarded in fiscal year 2026· until 2031. aug.

• NIH NIAMS · K23

  Tailored Exercise Interventions for Patients with Axial Spondyloarthritis: Targeting Sex-Based Challenges to Improve Clinical Outcomes

  University of Washington· Seattle, Egyesült Államok· 169 668 USD awarded in fiscal year 2026· until 2031. ápr.

• European Commission (Horizon Europe) · HORIZON-IA

  CANVAS: STREET FURNITURE AS A CANVAS - BEAUTY, INCLUSION AND SUSTAINABILITY IN PUBLIC SPACE

  Ait Austrian Institute of Technology Gmbh· Wien, Ausztria· EU contribution 5 110 818 EUR· until 2030. aug.· 10 countries

• European Commission (Horizon Europe) · HORIZON-JU-RIA

  SAFETY, EFFECTIVENESS AND COST-EFFECTIVENESS OF PROBIOTICS AS ADJUNCT PREVENTIVE THERAPY FOR CHILDHOOD DIARRHOEA AND ANTIMICROBIAL RESISTANCE IN AFRICA: A DOUBLE BLINDED RANDOMIZED CONTROLLED TRIAL (PRoRota)

  Universitetet I Bergen· Bergen, Norvégia· EU contribution 5 299 999 EUR· until 2030. ápr.· 4 countries

• European Commission (Horizon Europe) · HORIZON-JU-RIA

  NEXT-GENERATION SCALABLE AEM ELECTROLYZERS AS SUSTAINABLE HYDROGEN PRODUCTION SYSTEM (NEREUS)

  Antares Electrolysis S.r.l.· Genova, Olaszország· EU contribution 3 999 786 EUR· until 2029. febr.· 7 countries

• European Commission (Horizon Europe) · HORIZON-CSA

  OPERATING OPEN RESEARCH EUROPE AS A NON-PROFIT OPEN ACCESS SCIENTIFIC PUBLISHING SERVICE FOR THE PUBLIC GOOD (ORE 2.0)

  Organisation Europeenne Pour la Recherche Nucleaire· Geneve 23, Svájc· EU contribution 9 996 090 EUR· until 2030. dec.

• European Commission (Horizon Europe) · HORIZON-RIA

  CARBON-NEUTRAL PRODUCTION AND DIRECT FUEL-CELL DEPLOYMENT OF ISOPROPANOL AS ENERGY CARRIER (IsoPROPEL)

  Agencia Estatal Consejo Superior de Investigaciones Cientificas· Madrid, Spanyolország· EU contribution 3 995 636 EUR· until 2029. ápr.· 8 countries

10 of 44 running projects, newest first. Listed amounts together: 10,9 M USD + 89,0 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 7
• Mendelian Randomization Analysis 20
• Gene Expression Profiling 12
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 1
• Exome Sequencing 2
• Proteomics 9
• Metabolomics 5
• Flow Cytometry 3
• Magnetic Resonance Imaging 72
• Machine Learning 10
• Deep Learning 8
• Cohort Studies 24
• Genome-Wide Association Study 24

• Association of 14 matrix metalloproteinases and 4 tissue inhibitors of metalloproteinases on ankylosing spondylitis: A bidirectional Mendelian randomization study.

  Medicine (Baltimore), 2026. okt.

• Association between ankylosing spondylitis and hearing loss: A Mendelian randomization study.

  Medicine (Baltimore), 2026. okt.

• Association between inflammatory bowel disease and ankylosing spondylitis: Mendelian randomization of a different database and meta-analysis.

  Medicine (Baltimore), 2026. júl.

• Exploring causal associations between autoimmune diseases and hearing loss: a mendelian randomization study.

  Braz J Otorhinolaryngol, 2026. máj.

• Uncovering Causal Links Between Autoimmune Diseases and Muscular Dystrophy: A Bidirectional Mendelian Randomization Study.

  OMICS, 2026. máj.

• Two-sample Mendelian randomization analysis unveils a potential genetic association between rheumatic diseases and the risk of idiopathic pulmonary fibrosis.

  Medicine (Baltimore), 2026. máj.

• Mendelian randomization analysis links HLA-DR+ CD14- CD16+ monocytes to CCL19-driven ankylosing spondylitis risk.

  Medicine (Baltimore), 2026. máj.

• Causal relationship between autoimmune diseases and iron deficiency anemia: a two-sample mendelian randomization study.

  Sci Rep, 2026. ápr.

• Integrated stress response genes as novel biomarkers and therapeutic targets in ankylosing spondylitis: a transcriptomic and Mendelian randomization study.

  Front Immunol, 2026. márc.

• Characterizing the effects of genetic liability to autoimmune conditions on pregnancy outcomes using Mendelian randomization.

  BMC Med, 2026. márc.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.